Loop Industries (LOOP) risk factors, FY2025 10-K

Loop Industries's FY2025 10-K, filed May 29, 2025, lists 29 risk factors in 2 groups. There is no earlier 10-K to compare against, so the most company-specific risks are listed below.

Risk factors listed
292 groups
Section length
9k wordsItem 1A

Loop Industries's biggest risks in the FY2025 10-K

  • Loop Industries is an early-stage plastics technology company dependent on continuous external financing and scaling its depolymerization process.
  • Operations face significant hurdles from ongoing SEC investigations, customer and partner concentration, and heavy dependence on CEO Daniel Solomita.

The risks most specific to Loop Industries

  • RISKS RELATING TO OUR BUSINESS AND TECHNOLOGY

    We have incurred net losses since inception. We expect to continue to incur losses for the foreseeable future and may never achieve or maintain profitability

    We incurred a net loss of $15.1 million for the year ended February 28, 2025, and have earned limited revenues to date.

  • RISKS RELATING TO OUR BUSINESS AND TECHNOLOGY

    Disruption at, damage to, or destruction of our Terrebonne Facility could impede our ability to continue innovating and refining our technological process, and supporting our commercial projects, which would harm our business, financial condition, and operating results

    Our research and development activities are dependent on a single facility located in Terrebonne, Québec.

  • RISKS RELATING TO OUR BUSINESS AND TECHNOLOGY

    Our joint venture with Ester to construct and operate a manufacturing facility in India involves significant risks, and any delays or disruptions could adversely affect our business, financial condition, and prospects

    Our joint venture with Ester aims to construct an Infinite Loop India facility to produce 70,000 tons of PET resin and polyester fiber per year.

  • Risks related to this joint venture and facility construction include, but are not limited to

    We are subject to an SEC Investigation which could have a material adverse impact on our business, financial condition, results of operation, cash flows and reputation

    An ongoing SEC investigation regarding testing results for our GEN I and GEN II technologies could materially impact our business and reputation.

  • Risks related to this joint venture and facility construction include, but are not limited to

    Our current arrangements contain certain restrictions and potential cash obligations, and raising additional funds may cause dilution to our existing stockholders, restrict our operations or require us to relinquish rights to our technologies

    Our Series B CPS issued to an affiliate of Reed carries a 13% cumulative annual PIK dividend and is redeemable on its fifth anniversary.

  • Risks related to this joint venture and facility construction include, but are not limited to

    Our President and Chief Executive Officer and Chairman of the Board of Directors, Mr. Daniel Solomita, beneficially owns a majority of the total voting power of our capital stock, and accordingly, has control over stockholder matters, our business and management

    CEO Daniel Solomita owns 40.0% of our common stock and holds a Series A Preferred Stock share, giving him majority voting control.

  • Risks related to this joint venture and facility construction include, but are not limited to

    Sales of a significant number of shares of our common stock in the public markets, or the perception that such sales could occur could depress the market price of our common stock and impair our ability to raise capital through the sale of additional equity securities

    We have an active shelf registration statement on Form S-3 to offer up to $175 million in securities.

All 29 risk factors

Headings as the filing states them, in filing order.

RISKS RELATING TO OUR BUSINESS AND TECHNOLOGY

  1. 01We have incurred net losses since inception. We expect to continue to incur losses for the foreseeable future and may never achieve or maintain profitability
  2. 02We may not be able to execute our business plan or stay in business without additional funding
  3. 03Conditions in the financial markets and economic conditions in general may adversely affect our ability to raise additional capital, execute our business plan or remain in business
  4. 04Our technology may not be successful in developing commercial products
  5. 05We face business risks due to our relationships with strategic partners and other factors that may affect our joint venture endeavors
  6. 06If we are unable to successfully scale our manufacturing processes, we may not meet customer demand
  7. 07Disruption at, damage to, or destruction of our Terrebonne Facility could impede our ability to continue innovating and refining our technological process, and supporting our commercial projects, which would harm our business, financial condition, and operating results
  8. 08Our joint venture with Ester to construct and operate a manufacturing facility in India involves significant risks, and any delays or disruptions could adversely affect our business, financial condition, and prospects

Risks related to this joint venture and facility construction include, but are not limited to

  1. 09Failure to achieve expected operating efficiencies or projected economic returns
  2. 10We may not realize the expected benefits and may face risks associated with our licensing arrangements, and our ability to continue to generate significant revenue from technology licensing may be limited or delayed
  3. 11We operate in a highly competitive and rapidly evolving industry, and increased competition or technological advances could adversely affect our business, financial condition, and results of operations
  4. 12We are vulnerable to fluctuations in the supply and price of raw materials
  5. 13The loss of the services of Mr. Daniel Solomita, our President and Chief Executive Officer, and Chairman of the Board of Directors, or our failure to timely identify and retain competent personnel could negatively impact our ability to develop our business
  6. 14We are subject to certain risks related to litigation filed by or against us and investigations we are subject to, and adverse results may harm our business
  7. 15We are subject to an SEC Investigation which could have a material adverse impact on our business, financial condition, results of operation, cash flows and reputation
  8. 16Our failure to protect our intellectual property and proprietary technology may significantly impair our competitive advantage
  9. 17We may face costly intellectual property infringement claims, the result of which would decrease the amount of cash available to operate and complete our business plan
  10. 18We rely in part on trade secrets to protect our technology, and our failure to obtain or maintain trade secret protection could harm our business
  11. 19If our information technology systems or data, or those of third parties upon which we rely, are or were compromised, we could experience material adverse effects on our business, financial condition, results of operations and prospects
  12. 20If we fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately or timely report our financial condition or results of operations, which may adversely affect investor confidence in us and the price of our common stock
  13. 21We are subject to risks associated with currency fluctuations, and changes in foreign currency exchange rates could impact our results of operations
  14. 22We are subject to extensive and evolving domestic and global legal and regulatory requirements, and failure to obtain or maintain necessary approvals and comply with applicable laws could adversely affect our ability to commercialize our technology and operate our business
  15. 23Our current arrangements contain certain restrictions and potential cash obligations, and raising additional funds may cause dilution to our existing stockholders, restrict our operations or require us to relinquish rights to our technologies
  16. 24Trading volume in our stock can fluctuate and an active trading market for our common stock may not be available on a consistent basis to provide stockholders with adequate liquidity. Our stock price may be volatile, and our stockholders could incur significant investment losses
  17. 25other factors described elsewhere in these Risk Factors
  18. 26Our President and Chief Executive Officer and Chairman of the Board of Directors, Mr. Daniel Solomita, beneficially owns a majority of the total voting power of our capital stock, and accordingly, has control over stockholder matters, our business and management
  19. 27Anti-takeover effects of certain provisions of Nevada state law hinder a potential takeover of our company
  20. 28Because we do not intend to pay any cash dividends on our common stock, our stockholders will not be able to receive a return on their shares unless they sell them
  21. 29Sales of a significant number of shares of our common stock in the public markets, or the perception that such sales could occur could depress the market price of our common stock and impair our ability to raise capital through the sale of additional equity securities

Other Loop Industries 10-Ks

  • FY2026 10-K risk factors
    28 risks1 new2 dropped4 reworded

    Commercial-scale validation is now the central technology risk; Terrebonne remains only a small research and development plant.

    Filed May 27, 2026

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.